close read more

COVID-19: Beware of non-approved drugs and fake remedies!


COVID-19: Beware of non-approved drugs and fake remedies!

The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), of which Servier has been a member since September 2018, has just launched, through its Fight the Fakes movement, an awareness campaign to warn of the risks of fake treatments and vaccines alleged to treat COVID-19.

“There is currently no approved treatment, vaccine or cure for COVID-19, and we are not only fighting a virus, we are also fighting an “infodemic. This is the theme of this campaign, to be relayed widely on social networks.

Deeply concerned about the rapid spread of the new coronavirus (COVID-19) and the World Health Organization (WHO) declaration of a pandemic, Fight the Fakes and the entire global health community are sounding the alarm.

The use of fake products and medicines, moreover without medical supervision, means a major risk to the health and safety of patients. These products are potentially dangerous and could increase resistance to real treatments and lead to new diseases, disability or even death.

An “infodemic” that threatens the population

Public concern about this new unknown danger leads some people to treat and protect themselves in their own way.

Misleading advertisements for treatments and vaccines, rumors of so-called cures… many false promises are circulating on the Internet about treating, protecting, and curing oneself from COVID-19. This epidemic of fake news is a threat to the public and has just been qualified as an “infodemic” by the WHO.

Created by the IFPMA, Fight the Fakes is a global movement of public health organizations and individuals personally affected by the use of fake medicines. Its objective is to highlight the consequences of this scourge to the community in order to put an end to it.

Read the statement and share it on social networks


Read more on the WHO website


Last news

Meeting the challenge of adherence: a Servier study presented at the ESH 2022 Annual Meeting!
Appointment of Angelo Paci, Oncology & Immuno-Oncology Program Leader
Patient associations’ perception of pharmaceutical companies: Servier is making progress!